Ixaka

Ixaka

A clinical stage cell and gene therapy company focused on the natural power of the body to cure disease. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€192—288m (Dealroom.co estimates Jan 2021.)
Company register number 09427131
London England (HQ)
Authorizing premium user...